Recently, the glycolytic enzyme ENO1 has attracted the attention of oncologists because it is dys-regulated in various cancer types, including gastric cancer, HCC, glioma and pancreatic cancer [14,30–32]. Here, HK1 is linked to familial pancreatic carcinoma.